Jennifer L Griffin

US Patent:

20030198975, Oct 23, 2003

Filed:

Oct 31, 2002

Appl. No.:

10/287218

Inventors:

Yalda Azimzai - Oakland CA, US
Janice Au-Young - Brisbane CA, US
Sajeev Batra - Oakland CA, US
Mariah Baughn - San Leandro CA, US
Shanya Becha - Castro Valley CA, US
Mark Borowsky - Redwood City CA, US
Neil Burford - Durham CT, US
Li Ding - Creve Coeur MO, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ameena Gandhi - San Francisco CA, US
Kimberly Gietzen - San Jose CA, US
Jennifer Griffin - San Jose CA, US
April Hafalia - Santa Clara CA, US
Cynthia Honchell - San Carlos CA, US
Preeti Lal - Santa Clara CA, US
Soo Lee - Daly City CA, US
Dyung Aina Lu - San Jose CA, US
Chandra Arvizu - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Roopa Reddy - Sunnyvale CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Y. Tom Tang - San Jose CA, US
Narinder Chawla - Union City CA, US
Yu-Mei Wang - Mountain View CA, US
Bridget Warren - Encinitas CA, US
Yuming Xu - Mountain View CA, US
Junming Yang - San Jose CA, US
Monique Yao - Carmel IN, US
Henry Yue - Sunnyvale CA, US
Yeganeh Zebarjadian - San Francisco CA, US

Assignee:

Incyte Genomics, Inc. - Palo Alto CA

International Classification:

C12Q001/68
C07H021/04
C12N009/00
C12P021/02
C12N005/06
C07K014/47
A61K048/00

US Classification:

435/006000, 435/069100, 435/183000, 435/320100, 435/325000, 530/350000, 536/023200, 530/388260, 514/044000

Abstract:

The invention provides human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.

US Patent:

20040023245, Feb 5, 2004

Filed:

May 27, 2003

Appl. No.:

10/311764

Inventors:

Janice Au-Young - Brisbane CA, US
Mariah Baughn - San Leandro CA, US
Li Ding - Creve Coeur MO, US
Vicki Elliott - San Jose CA, US
Ameena Gandhi - San Francisco CA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Liam Kearney - San Francisco CA, US
Ernestine Lee - Castro Valley CA, US
Yan Lu - Mountain View CA, US
Danniel Nguyen - San Jose CA, US
Chandra Arvizu - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Roopa Reddy - Fremont CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Elizabeth Stewart - Mill Creek WA, US
Y Tang - San Jose CA, US
Michael Thornton - Oakland CA, US
Catherine Tribouley - San Francisco CA, US
Narinder Chawla - Union City CA, US
Junming Yang - San Jose CA, US
Monique Yao - Carmel IN, US
Henry Yue - Sunnyvale CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/16
C12P021/02
C12N005/06

US Classification:

435/006000, 435/069100, 435/196000, 435/320100, 435/325000, 536/023200

Abstract:

The invention provides human protein phosphatases (PP) and polynucleotides which identify and encode PP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PP.

US Patent:

20040086887, May 6, 2004

Filed:

Mar 27, 2003

Appl. No.:

10/381898

Inventors:

Yalda Azimzai - Oakland CA, US
Mariah Baughn - San Leandro CA, US
Mark Borowsky - Redwood City CA, US
Li Ding - Creve Coeur MO, US
Brendan Duggan - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Ameena Gandhi - San Francisco CA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Craig Ison - San Jose CA, US
Farrah Khan - Des Plaines IL, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Castro Valley CA, US
Dyung Lu - San Jose CA, US
Danniel Nguyen - San Jose CA, US
Chandra Arvizu - San Jose CA, US
Jennifer Policky - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Huizun Ring - Foster City CA, US
Madhusudan Sanjanwala - San Jose CA, US
Y Tang - San Jose CA, US
Catherine Tribouley - San Francisco CA, US
Narinder Chawla - Union City CA, US
Roderick Walsh - Canterbury, GB
Bridget Warren - Encinitas CA, US
Yuming Xu - Mountain View CA, US
Junming Yang - San Jose CA, US
Monique Yao - Carmel IN, US
Henry Yue - Sunnyvale CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/00
C07K016/40

US Classification:

435/006000, 435/069100, 435/183000, 435/320100, 435/325000, 530/388260, 536/023200

Abstract:

The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.

US Patent:

20040132043, Jul 8, 2004

Filed:

Oct 6, 2003

Appl. No.:

10/474291

Inventors:

Yalda Azimzai - Oakland CA, US
Janice Au-Young - Brisbane CA, US
Sajeev Batra - Oakland CA, US
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Mark Borowsky - Northampton MA, US
Neil Burford - Durham CT, US
Li Ding - Creve Couer MO, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ameena Gandhi - San Francisco CA, US
Kimberly Gietzen - San Jose CA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Cynthia Honchell - San Carlos CA, US
Preeti Lal - Santa Clara CA, US
Soo Lee - Mountain View CA, US
Dyung Aina Lu - San Jose CA, US
Chandra Arvizu - San Diego CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Roopa Reddy - Fremont CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Y Tang - San Jose CA, US
Narinder Chawla - Union City CA, US
Yu-Mei Wang - Mountain View CA, US
Bridget Warren - San Marcos CA, US
Yuming Xu - Mountain View CA, US
Junming Yang - Sa Jose CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Yeganeh Zebarjadian - San Francisco CA, US

International Classification:

C12Q001/68
C07H021/04
C07K014/47
C12N015/00

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

The invention provides human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.

US Patent:

20040138416, Jul 15, 2004

Filed:

Sep 30, 2003

Appl. No.:

10/473518

Inventors:

Michael Thornton - Oakland CA, US
Monique Yao - Mountain View CA, US
Thomas Richardson - Redwood City CA, US
Anita Swarnakar - San Francisco CA, US
Deborah Kallick - Galveston TX, US
Craig Ison - San Jose CA, US
Narinder Chawla - Union City CA, US
Ameena Gandhi - San Francisco CA, US
Ernestine Lee - Kensington CA, US
Vicki Elliott - San Jose CA, US
April Hafalia - Daly City CA, US
Janice Au-Young - Brisbane CA, US
Jennifer Griffin - Fremont CA, US
Mariah Baughn - Los Angeles CA, US
Farrah Khan - Des Plaines IL, US
Shanya Becha - San Francisco CA, US
Yan Lu - Mountain View CA, US
Chandra Arvizu - San Diego CA, US
Mark Borowsky - North Hampton MA, US
Preeti Lal - Santa Clara CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Brooke Emerling - Chicago IL, US
Roderick Walsh - Sandwich, GB
Henry Yue - Sunnyvale CA, US
Neil Burford - Durham CT, US
Richard Graul - San Francisco CA, US

International Classification:

C12N005/06
C07K014/705
C12Q001/68
C07H021/04

US Classification:

530/350000, 435/006000, 435/069100, 435/320100, 435/325000, 536/023500

Abstract:

The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.

US Patent:

20040203014, Oct 14, 2004

Filed:

Mar 12, 2004

Appl. No.:

10/489372

Inventors:

Cynthia Honchell - San Francisco CA, US
Bridget Warren - San Marcos CA, US
Mark Borowsky - Needham MA, US
Jennifer Griffin - Fremont CA, US
Joana Li - Millbrae CA, US
Soo Lee - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Ian Forsythe - Edmonton, CA
Joseph Marquis - San Jose CA, US
Kimberly Gietzen - San Jose CA, US
Mariah Baughn - Los Angeles CA, US
Uyen Tran - San Jose CA, US
Y. Tang - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Brooke Emerling - Chicago IL, US
Ernestine Lee - Kensington CA, US
Vicki Elliott - San Jose CA, US
April Hafalia - Daly City CA, US
Brendan Duggan - Sunnyvale CA, US
Narinder Chawla - Union City CA, US
Amy Kable - Silver Spring MD, US
Hsin-Ru Chang - Belmont CA, US
Reena Khare - Saratoga CA, US
Shanya Becha - San Francisco CA, US
Pei Jin - Palo Alto CA, US
Sally Lee - San Jose CA, US

International Classification:

C12Q001/68
C07H021/04
C12N015/00
C07K014/705

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

Various embodiments of the invention provide human neurotransmission-associated proteins (NTRAN) and polynucleotides which identify and encode NTRAN. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NTRAN.

US Patent:

20040249128, Dec 9, 2004

Filed:

Jul 19, 2004

Appl. No.:

10/483512

Inventors:

Michael Thornton - Oakland CA, US
Janice Au-Young - Brisbane CA, US
Yalda Azimzai - Oakland CA, US
Olga Bandman - Mountain View CA, US
Ines Barroso - Cambridge CA, US
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Mark Borowsky - Needham MA, US
Li Ding - Creve Coeur MO, US
Brendan Duggan - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ian Forsythe - Edmonton, CA
Ameena Gandhi - San Francisco CA, US
Kimberly Gietzen - San Jose CA, US
Ann Gorvad - Bellingham WA, US
Jennifer Griffin - Fremont CA, US
Rajagopal Gururajan - San Jose CA, US
April Hafalia - Daly City CA, US
Huijun Ring - Foster City CA, US
Craig Ison - San Jose CA, US
Karen Jones - Bollington, GB
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Sally Lee - San Jose CA, US
Joana Li - Millbrae CA, US
Dyung Aina Lu - San Jose CA, US
Joseph Marquis - San Jose CA, US
Narinder Chawla - Union City CA, US
Chandra Arvizu - San Diego CA, US
Bharati Sanjanwala - Los Altos CA, US
Thierry Sornasse - Mountain View CA, US
Anita Swarnakar - San Francisco CA, US
Y Tom Tang - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Bao Tran - Cupertino CA, US
Uyen Tran - San Jose CA, US
Bridget Warren - San Marcos CA, US
Yuming Xu - Mountain View CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Huibin Yue - Cupertino CA, US
Yeganeh Zebarjadian - San Francisco CA, US
Hsin-Ru Chang - bELMONT CA, US

International Classification:

C07H021/04
C07K014/705
C12N005/06

US Classification:

530/350000, 435/069100, 435/320100, 435/325000, 536/023500

Abstract:

Various embodiments of the invention provide human molecules for disease detection and treatment (MDDT) and polynucleotides which identify and encode MDDT. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MDDT.

US Patent:

20050019763, Jan 27, 2005

Filed:

Apr 5, 2002

Appl. No.:

10/473451

Inventors:

Ameena Gandhi - San Francisco CA, US
Angelo Delegeane - Milpitas CA, US
Anita Swarnakar - San Francisco CA, US
April Hafalia - Daly City CA, US
Brendan Duggan - Sunnyvale CA, US
Bridget Warren - San Marcos CA, US
Brooke Emerling - Chicago IL, US
Chandra Arvizu - San Diego CA, US
Cynthia Honchell - San Carlos CA, US
Deborah Kallick - Galveston TX, US
Dyung Lu - San Jose CA, US
Ernestine Lee - Kensington CA, US
Henry Yue - Sunnyvale CA, US
Ian Forsythe - Edmonton, CA
Jayalaxmi Ramkumar - Fremont CA, US
Jennifer Griffin - Fremont CA, US
Joana Li - Millbrae CA, US
Kavitha Thangavelu - Sunnvyale CA, US
Mariah Baughn - Los Angeles CA, US
Monique Yao - Mountain View CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Narinder Chawla - Union City CA, US
Neil Burford - Durham CT, US
Preeti Lal - Santa Clara CA, US
Shanya Becha - San Francisco CA, US
Soo Lee - Mountain View CA, US
Vicki Elliott - San Jose CA, US
Wen Luo - San Diego CA, US
Yan Lu - Mountain View CA, US
Yu-mei Wang - Mountain View CA, US

International Classification:

C12Q001/68
A01K067/00
C07H021/04
C12N009/64

US Classification:

435006000, 435069100, 435226000, 435320100, 435325000, 536023200, 800008000

Abstract:

The invention provides human protein modification and maintenance molecules (PMOD) and polynucleotides which identify and encode PMOD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMOD.